Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma : A multicentre, single-arm phase I/II clinical trial
dc.contributor.author | Pili, R. | |
dc.contributor.author | Liu, G. | |
dc.contributor.author | Chintala, S. | |
dc.contributor.author | Verheul, H. | |
dc.contributor.author | Rehman, S. | |
dc.contributor.author | Attwood, K. | |
dc.contributor.author | Lodge, M. | |
dc.contributor.author | Wahl, R. | |
dc.contributor.author | Martin, J. | |
dc.contributor.author | Godoy Sánchez, Alejandro Samuel | |
dc.contributor.author | Miles, K. | |
dc.contributor.author | Paesante, S. | |
dc.contributor.author | Adelaiye, R. | |
dc.contributor.author | King, S. | |
dc.contributor.author | Zwiebel, J. | |
dc.contributor.author | Carducci, M. | |
dc.date.accessioned | 2021-05-22T01:08:50Z | |
dc.date.available | 2021-05-22T01:08:50Z | |
dc.date.issued | 2017 | |
dc.format.extent | 10 páginas | |
dc.fuente.origen | Converis | |
dc.identifier.doi | 10.1038/bjc.2017.33 | |
dc.identifier.eissn | 1532-1827 | |
dc.identifier.issn | 0007-0920 | |
dc.identifier.uri | https://doi.org/10.1038/bjc.2017.33 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/58573 | |
dc.issue.numero | No. 7 | |
dc.language.iso | en | |
dc.nota.acceso | Contenido completo | |
dc.pagina.final | 883 | |
dc.pagina.inicio | 874 | |
dc.revista | British Journal of Cancer | es_ES |
dc.rights | acceso abierto | |
dc.title | Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma : A multicentre, single-arm phase I/II clinical trial | es_ES |
dc.type | artículo | |
dc.volumen | Vol. 116 | |
sipa.codpersvinculados | 1011486 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal.pdf
- Size:
- 1.4 MB
- Format:
- Adobe Portable Document Format
- Description: